Revista Espanola de Quimioterapia

Papers
(The H4-Index of Revista Espanola de Quimioterapia is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
Cefiderocol65
47
Evaluation of two immunocromatographic tests for the detection of antibodies against SARS-CoV-245
35
COVID-19 in donation and transplant35
Mechanical ventilation associated pneumonia during ECMO therapy. A challenge for the Intensive Care physician25
Prevalence of SARS-CoV-2 infection during the first wave of the pandemic among health and non-health personnel of the General Hospital of Segovia, Castilla y León24
Application of CMO (capacity, motivation, and opportunity) methodology in pharmaceutical care to optimize the pharmacotherapy in older people living with HIV. DISPIMDINAC project19
Systemic absorption of liposomal inhaled amikacin in the treatment of resistant Mycobacterium avium: beyond expectations18
Usefulness of monocyte distribution width (MDW) as a sepsis biomarker17
Invasive group A Streptococcus infection (Streptococcus pyogenes): Current situation in Spain17
Interactions listed in the Paxlovid fact sheet, classified according to risks, pharmacological groups, and consequences17
COVID-19: Impact on prescribing and antimicrobial resistance17
Is Propionimicrobium lymphophilum a new urinary tract infection cause?16
Influence of epidemiological and clinical factors in the reactogenicity to Comirnaty® vaccine in health care workers of a Spanish university teaching hospital (COVIVAC study)15
Persistence and viability of SARS-CoV-2 in primary infection and reinfections15
0.093465089797974